Caplight Directory>Companies>Carus Bio-preview>Carusbio


Carus Bio

Carus Bio

Private
SeoulN/Ahttps://carusbio.com/

Last Round

VC Round

Apr 1, 2025

Total Funding Raised

$8.85M

Company Overview

Carus Bio is a biotechnology company that develops a drug delivery platform, BioDrone™, based on cell-derived vesicles for in vivo CAR-T therapies.

Keywords

drug delivery platformcell-derived vesiclesCDVstargeted drug deliveryin vivo CAR-Textracellular vesiclesexosome drug deliveryCAR-T therapyvesicle technologybiologics deliverygene therapy deliverybiotech platform licensingcancer therapeuticsmRNA delivery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Carus Bio Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Carus Bio Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 1, 2025
Series BAug 27, 2019
Series ASep 30, 2016
View all Funding Rounds

Carus Bio Investors

Notable investors and investment history

InvestorRounds
(주)스마트앤그로스VC Round
DAYLI PartnersSeries B
KCLAVIS InvestmentSeries B
The Wells InvestmentSeries B
QUAD Investment ManagementSeries B
InterValue PartnersSeries B
STIC VenturesSeries B
View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2025

    Raised a VC Round with (주)스마트앤그로스 as an investor.

  • Aug 27, 2019

    $9M round with participation from KCLAVIS Investment and QUAD Investment Management.

View all signals

Carus Bio Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Carus Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Carus Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Year Founded2015
Last FundingApr 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.